Servier

Three blocks displaying from left to right a person a handshake and another person
Biotech

Servier inks $2.6B buyout of Edgewise’s muscular dystrophy unit

Servier agreed to buy the muscular dystrophy business for $1.55 billion upfront, gaining control of a drug that could deliver pivotal data this year.
Nick Paul Taylor Jun 1, 2026 8:31am
An arrow incrementally going up stairs before pointing straight up Blue background

Ideaya and Servier report eye cancer win, clearing path to FDA

Apr 13, 2026 7:08am
medicine artificial intelligence

Lilly embraces AI biotech Insilico again, inking $2.75B collab

Mar 29, 2026 8:00pm
no longer in business sign

Molecular glue biotech f5 Therapeutics closes down

Mar 10, 2026 1:10pm
Servier
Favicon Fierce Pharma

Servier rounds out rare cancer offerings with $2.5B Day One buy

Mar 6, 2026 10:14am
A tied stack of one hundred dollar bills lying on a euro bills background

Biotech money moves: 3 new venture funds raise nearly $1B

Jan 9, 2026 1:20pm